Abstract--Programmed cell death, or apoptosis, may play an important role in the regulation of hematopoiesis. The tumor suppressor protein p53 has been identified as a key regulator of apoptosis in both normal and malignant hematopoietic cells. Modulation of p53 function is of interest, therefore, both in understanding the control of apoptosis and as a potential therapeutic intervention. In this study we describe the effect on murine erythroleukemia cells, transfected with a temperature-sensitive mutant p53, of exposure to the differentiating agent dimethylsulfoxide (DMSO). Rather than terminally differentiating, these cells are induced to undergo apoptosis. Interestingly, exposure to DMSO leads to an alteration of the protein conformation of the p53 mutant to one recognized by a wild-type specific monoclonal antibody. This is accompanied by a translocation of the p53 protein from the cytoplasm to the nucleus. These results suggest that the activity of some mutant p53 proteins can be functionally modified by exogenous compounds.
Introduction

PROGRAMMED
CELL DEATtt, or apoptosis, is now thought to be an important regulatory process in normal hematopoiesis and in tumor suppression. Hematopoietic progenitor cells are dependent on cytokines not only for proliferation but also to prevent apoptosis [1] . The genetic regulation of apoptosis is poorly understood. Yonish-Roach et al. have shown that re-introduction of wild-type p53 expression induces apoptosis in the murine M1 myeloid leukemic cell line [2] . This effect is inhibited by exposure of M1 cells to the growth factor interleukin-6 and enhanced by treatment with transforming growth factor beta [3] . Wild-type p53 expression is also necessary for some forms of induced apoptosis in normal hematopoietic cells [4] . In the murine erythroleukemia (MEL) cell line DP16-1, re-introduction of a temperature-sensitive p53 mutant (p53 yaH35) allows the effect of wild-type p53 expression to be studied by temperature downshift [5] . The p53 tS mutant behaves as a mutant p53 in cells cultured at 37°C; at 32.5°C the protein undergoes a conformational change to that recognized by wild-type specific antibodies and is translocated from the cytoplasm to the nucleus in rat embryo fibroblast cells [6, 7] . Transfer of DP16-1 MEL cells transfected with a p53 tS expression vector to 32.5°C results in G1 cell cycle arrest and subsequent apoptotic cell death [5] . This is accompanied by movement of p53 into the cell nucleus.
Murine erythroleukemia cells can be induced to differentiate into mature red cells by treatment with a number of chemical agents, including dimethylsulfoxide (DMSO). DP16-1 cells exposed to 1.6% DMSO will differentiate, as measured by benzidine staining for hemoglobin content, over a period of 4-5 days. When DP16-1 cells transfected with p53 ts are treated with DMSO at 37°C, apoptosis, rather than differentiation, ensues in the majority of cells. Antibody studies demonstrate that this is correlated with a conformational change in the p53 protein and nuclear localization. This finding suggests that p53 activity 
Materials and Methods
Stable p53 tS transfectants
p53tSneo contains the coding sequence of the neomycin resistance gene under the regulation of an SV40 promoter and the coding sequences of p53 val-135 linked to an RSV LTR promoter. This plasmid was derived from plasmid pLTRp53cG (a gift of M. Oren) as previously described [5] . p53tSneo was linearized with BamHI and transfected into DP16-1 MEL cells (a gift of S. Benchimol) by electroporation, as previously described [5] . Transfected cells were selected in DMEM media containing 1 mg of geneticin (G418,GIBCO) per ml. Single cell clones were isolated by limiting dilution in 96-well microtiter plates. To induce differentiation, logarithmically growing cells were grown in medium containing 1.6% DMSO (Sigma) for a total of 5 days. Media were changed every other day. Benzidine staining was performed as previously described [5] . Cell viability was measured by trypan blue exclusion.
p53 immunoprecipitation
Clone 9 cells were cultured at 37°C, with and without 1.6% DMSO, for 24 h and then labeled for 3 h with 0.2 mCi of [3sS] methionine. Immunoprecipitations were performed as previously described [5] , Lysates (2 x 106 cells) were precipitated with PAb421, a pan-specific monoclonal antibody against p53, PAb246, a routine p53-specific monoclonal antibody that recognizes wild-type p53, and PAb240, a p53-specific monoclonal antibody that recognizes an epitope present on mutant forms of p53 [7] . Untransfected parental DP16-1 MEL cells were immunoprecipitated with the same antibodies as a negative control. Immune complexes were collected with protein A agarose beads (Bethesda Research Laboratories), washed three times in lysis buffer, electrophoresed through 10% polyacrylamide in the presence of SDS and dried gels used for autoradiography.
Immunohistochemistry
Clone 9 cells were cultured at 37°C in the presence and absence of 1.6% DMSO for 24 h. Untransfected DP16-1 cells were grown at 37°C as a negative control. 2.5 x 105 cells were then suspended in FACS buffer [5] and pelleted on a microscope slide using a cytospin centrifuge (Shandon). Cells were fixed with methanol for 1 h at 4°C and then washed in PBS. Forty microliters of PAb421 were added to each slide for 1 h at room temperature. Following a PBS wash, 25 ~tl of GAM-FITC (Tago) were added for 1 h at room temperature. Staining was visualized by fluorescence microscopy.
Results
Several DP16-1 p53 t+ transfected subclones were studied by culture at 37°C in the presence of 1.6% DMSO. These clones have previously been shown to express p53-specific RNA and protein [5] . In contrast to the parental cell line DP16-1, which maintains viability and differentiates over a 4-5 day period (Table 1) , the p53 t+ transfectants lose viability, with most cells dying prior to developing positive benzidine staining. Data for a representative clone, C9, are shown in Table 1 . Apoptosis is characterized by activation of an endogenous endonuclease leading to fragmentation of genomic DNA secondary to internucleosomal cleavage. This pattern is clearly seen in C9 cells exposed to 1.6% DMSO for 24 h, while only high molecular weight DNA is extracted from similarly treated DP16-1 cells (Fig. 1) . This is consistent with an induction of apoptosis by p53 in the DMSO-treated p53 t~ transfectants.
Immunohistochemistry was then performed on C9 cells growing at 37°C with and without 1.6% DMSO for 24 h. p53 staining clearly showed a nuclear pattern in DMSO-treated cells, as compared with the expected cytoplasmic staining of untreated cells (Fig.  2) . Parental DP16-1 cells showed no p53-specific staining.
To examine whether a conformational change in the p53 t~ protein occurs with nuclear translocation, we performed p53 immunoprecipitations on C9 cells growing in 1.6% DMSO. The monoclonal antibody PAb246 is specific for an epitope of the wild-type murine p53 conformation. At 37°C less than 5% of the p53 '~ protein can be precipitated with PAb246, while a significantly higher proportion can be precipitated at 32.5°C [7, 8] . The mutant-specific monoclonal antibody PAb240 can detect the majority of p53 protein at 37°C; these results are confirmed in C9 cells cultured at 37°C in the absence of DMSO (Fig. 3) . Figure 4 shows that in DMSO-treated C9 cells at 37°C a significant proportion of the total p53 protein (as detected by the pan-specific antibody PAb421) is recognized by PAb246. In contrast, much less protein is precipitated with the mutant p53-specific monoclonal antibody PAb240. This is consistent with a shift to a wild-type protein conformation secondary to DMSO exposure and would explain the observed nuclear localization of the p53 protein.
Discussion
The subcellular location of p53 is thought to modulate its actions. Mutant forms of the protein are often associated with the heat shock protein hsp 70 and localized in the cytoplasm [9] . The temperature-sensitive mutant used in these experiments is localized in the cytoplasm when cells are grown at 37°C (when the protein is in a mutant conformation) and translocates into the nucleus when cells are grown at 32.5°C (when the p53 is in a wild-type conformation). In p53 tS MEL cells nuclear localization of the p53 protein is associated with G1 growth arrest and apoptosis [5] . Interleukin-6 treatment of M1 myeloid leukemia cells inhibits p53-induced apoptosis without affecting nuclear translocation [10] . The factors regulating transport of p53 intracellularly are not known. Evidence has been presented that a short-lived protein is responsible for anchoring mutant p53 in the cytoplasmic compartment [11] . Downregulation of this putative protein might, therefore, allow entry of p53 into the nucleus. Alternatively, a change in p53 protein conformation may allow release from a cytoplasmic anchoring protein.
In this study exposure of p53 t~ transfected MEL cells to DMSO resulted in nuclear translocation of the p53 protein. Immunoprecipitation data support the concept that a change in protein conformation allows entry into the nucleus. The p53 is functionally active and fundamentally alters the phenotype of cells cultured in DMSO. During normal myeloid differentiation p53 protein levels increase [12] . Entry of p53 into the nuclear compartment during induced differentiation may be important in its role as a tumor suppressor protein; apoptosis would be induced in those cells with extensive DNA damage or genetic alterations while differentiation would be promoted in less mutated cells. This idea is supported by the finding that wild-type p53 can promote differentiation in a chronic myelogenous leukemia cell line [13] , as well as in murine erythroleukemia cells ( [8] , Ryan J. & Clarke M. F., unpublished observations). An understanding of the factors regulating the subcellular localization of p53 will be an important step in the development of targeted cancer therapeutics. Conformational analysis of p53 ts protein in clone 9 cells, p53 was immunoprecipitated using conformationspecific monoclonal antibodies [7] from labeled clone 9 cells exposed to 1.6% DMSO for 24 h. A significant proportion of the total p53 protein (precipitated with PAb421) is recognized by the wild-type specific antibody PAb246 while a smaller percentage is recognized by the mutant conformation specific antibody PAb240.
